Loading company…
Synthetic Vaccine Biotech develops vaccines, adjuvants and antibody-based therapies.
Synthetic Vaccine Biotech is a biotechnology company founded in 2020 and based in Beijing, China. It develops vaccines, adjuvants and antibody-drug conjugates, alongside biomedical research for clinical and commercial use. The company raised Series B funding in July 2025.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in